Trifecta Signals

← Stocks · CLDI page

Calidi Biotherapeutics, Inc. (CLDI)

Price chart & company basics · Trifecta Signals

$0.68-$0.05 (-6.81%)Close · Thu, Nov 5, 2026

Price refreshes every trading day after the close.

In the scan since Jan 2022
CLDI closes
-97.2% 1Y · Range $0.64 – $26.56
$10$20 Nov ’25Jan ’26Mar ’26May ’26Jul ’26Sep ’26Nov ’26

Daily closes · through the most recent close

Price history from Jan 2018 · Signal tracking began Jan 2022

The Trifecta List

CLDI didn’t make the Trifecta List

Calidi has never had a Trifecta signal in the record — not an Early signal, not a confirmed one — since the record began in January 2022. It is scanned after every trading day’s close along with the full US-listed universe; so far it has never met the conditions.

That’s the whole record for this stock: the chart and the basics above, and nothing to grade.

The list is the public track record: every stock that has signaled, logged, confirmed, and graded.

This page follows Calidi Biotherapeutics, which trades under the CLDI ticker.

Across the past year, closes have spanned $0.64 to $27, and the latest close sits near the bottom of that span. The low-to-high span over the year comes to about 4050%. Price history on this page reaches back to November 2021.

At the most recent close, Thursday, November 5, the shares finished at $0.68, down 6.8% on the day. Recent trading has kept the shares between about $0.66 and $0.75 over the past week.

Download the CLDI report (PDF)Free edition — public summary · Data as of Nov 4, 2026